CTLA4 and neoplasm: Some in vitro studies [26–28] demonstrated that co-inhibitory molecules programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) could attenuate glycolysis in CD8+ T cells and suppress their anti-tumor function.